Isabel Aznarez

Fundador en STOKE THERAPEUTICS, INC. .

54 años

Consumer Services

Commercial Services

Health Technology

Perfil

Isabel Aznarez is the founder of Stoke Therapeutics, Inc. since 2014, holding the title of Senior Vice President & Head-Research.
Dr. Aznarez is currently the Director of Oligonucleotide Therapeutics Society, Inc. since 2019.
Dr. Aznarez obtained a doctorate from the University of Toronto in 2006 and completed an undergraduate degree at Universidad De La Republica Uruguay.

Cargos activos de Isabel Aznarez

Empresas	Cargo	Inicio
STOKE THERAPEUTICS, INC.	Fundador	01/06/2014
Oligonucleotide Therapeutics Society, Inc. Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit forum for research and development of oligonucleotide therapeutics	Director/Miembro de la Junta	01/01/2019

Todos los cargos activos de Isabel Aznarez

Formación de Isabel Aznarez.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Isabel Aznarez.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	4
University of Toronto University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Oligonucleotide Therapeutics Society, Inc. Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit forum for research and development of oligonucleotide therapeutics	Commercial Services
Universidad De La Republica Uruguay Universidad De La Republica Uruguay Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Stoke Therapeutics, Inc. Stoke Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company focused on the development of first-in-class therapeutics that selectively increase gene expression to treat genetic diseases	Health Technology